• Teva Pharmaceutical Industries average return on equity for 2023 was -20.43, a 52.35% decline from 2022.
• Teva Pharmaceutical Industries average return on equity for 2022 was -13.41, a 9.15% increase from 2021.
• Teva Pharmaceutical Industries average return on equity for 2021 was -14.76, a 10.6% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.